CS1+ or BCMA+ Multiple Myeloma
1 clinical trials · Condition
◉ Watch CS1+ or BCMA+ Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| T Cells Expressing a Bispecific CAR Targeting CS1 and BCMA in Relapsed/Refractory Multiple Myeloma (NCT04662099) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2020-03-25 |
Track CS1+ or BCMA+ Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.